Patient engagement is a crucial responsibility of any gene therapy company that is serious about progressing safe, effective, and meaningful therapies to patients.

The 4th Gene Therapy Patient Engagement Summit is returning in 2024, sitting at the unique interface of patient engagement and gene therapy, from embarking on first-in-human trials through to commercial therapeutics.

Join 80+ patient advocacy and engagement professionals at gene therapy companies and patient advocacy groups to gain actionable insights that you can immediately implement into your own gene therapy programs, and come together with the community to develop solutions to the challenges that are unique to the gene therapy space.

Time: 9:00 AM – 4:00 PM

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices: USD 2199.00 – USD 4497.00

Speakers: Oscar Segurado, Clinical Development, ASC Therapeutics, Kara Fick, Director, Patient Advocacy and Medical Affairs, Atsena, and more